Jagpreet Chhatwal, PhD

Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Health Decision Science, Harvard University, Boston, Massachusetts

  • 1Article
  • 2025Active
  • 6Collaborators

About

Jagpreet Chhatwal, PhD is affiliated with Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Health Decision Science, Harvard University, Boston, Massachusetts. Jagpreet Chhatwal has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2025. Their work focuses on Depression (MDD).

Publications

JCP
Aripiprazole or Bupropion Augmentation vs Switching to Bupropion in Treatment Resistant Depression
Original Research

Aripiprazole or Bupropion Augmentation vs Switching to Bupropion in Treatment Resistant Depression

September 22, 2025

In this model, augmentation with bupropion better balanced efficacy and tolerability in TRD in adults under 85 than did switching to bupropion or augmentation with aripiprazole. Augmentation with aripiprazole...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe